TNF and myocarditis: Though it was not statistically significant, there was a higher rate of infliximab utilization in our cohort, especially in patients with elevated TNF-α, although this may have been related to more patients with elevated TNF-α having higher grade myocarditis and thus requiring immunomodulatory treatment beyond steroids.